How a Powerful Genetic Test Found a Life-Saving Therapy for an Infant's Rare Cancer
A new genetic test found that Quincy's aggressive blood cancer had an unusual mutation on the FLT3 gene. That gave Quincy’s doctors a life-saving idea.
University of California San Francisco
Give to UCSFA new genetic test found that Quincy's aggressive blood cancer had an unusual mutation on the FLT3 gene. That gave Quincy’s doctors a life-saving idea.
UCSF Benioff Children’s Hospitals have successfully treated a months-old infant with a rare childhood leukemia using a targeted therapy approved for adults with inoperable liver cancer and advanced kidney cancer.
Patients increasingly resort to crowdfunding websites to pay medical bills, a new UCSF study finds that online donations are sought for lost wages, child care and even occasionally experimental treatments.
Despite a broad campaign among physician groups to reduce the amount of imaging in medicine, the rates of use of CT, MRI and other scans have continued to increase.
A new web tool spells out for the first time the exposures that more than 6.5 million working women in California face that could increase their risk for breast cancer, including industrial solvents, antimicrobials and phthalates.
We talked with Lydia Zablotska, MD, PhD, about the real-life health impacts from the disaster portrayed in the HBO miniseries.
This documentary, about “a renegade scientist’s visionary quest to find a cure for cancer,” features immunologist James Allison, PhD, a residency alumnus and a former member of the UCSF and UC Berkeley faculties. Allison overcame many obstacles en route to his discovery of the immune system’s role in defeating cancer – work that won him a 2018 Nobel Prize. Narrated by Woody Harrelson, the film includes interviews with several current UCSF researchers, including Max Krummel, PhD, who as a graduate student in Allison’s UC Berkeley lab led several of the key studies recognized by the Nobel.
Using advanced technology, scientists have discovered an autoimmune disease that appears to affect men with testicular cancer.
Today, our understanding of glioma subtypes has expanded to include the molecular and genetic variants that can influence a tumor’s development, prognosis, and response to treatment.
Newly discovered radiation-resistant stem cells are normally rare and inactive (left), but they take on a major role in muscle repair when regular stem cells are damaged by radiation (right). Credit:
Janel Long-Boyle, a faculty member in the UCSF School of Pharmacy's Department of Clinical Pharmacy, has spent her career advancing lifesaving drugs.
UC San Francisco is collaborating with the nonprofit Lazarex Cancer Foundation on a three-year study to identify ways to improve cancer clinical trial participation among medically underserved populations, including low-income individuals and racial and ethnic minorities.
UC San Francisco scientists have designed a large-scale screen that efficiently identifies drugs that are potent cancer-killers when combined, but only weakly effective when used alone. Using this
Image courtesy of the National Cancer InstituteImmunotherapy drugs known as checkpoint inhibitors have revolutionized cancer treatment: many patients with malignancies that until recently would have
More than 150 people have signed up to shave their heads at UCSF Benioff Children’s Hospital Oakland on March 16, to support the 12th annual Brave the Shave fundraiser for pediatric cancer research.
Chemtai Mungo, MD, MPH, is committed to tackling the public health effects of gender inequality and helping to improve cervical cancer screening in Kenya.
Regular use of a common type of medication, such as aspirin and ibuprofen, significantly improves survival for a third or more patients with head and neck cancer, a new study led by UCSF has found.
UCSF's Thea Tlsty is a winner of the “Grand Challenge” competition sponsored by Cancer Research UK. Her international team will receive $26 million to uncover how chronic inflammation causes cancer.
In laboratory experiments, UCSF researchers successfully beat back the growth of aggressive liver cancers using a surprising new approach.
The amount of radiation that patients are exposed to from CT scans varies widely between institutions and countries, and is largely due to differences in the technical settings of the scanning machines.
Cynthia Perlis shares her top learnings from 30 years of listening to cancer patients at UCSF.
Study, led by UCSF, raises intriguing questions about whether the biology of low-risk prostate cancer in black men is distinct from that of other ethnicities.